BioNTech SE - ADR vs Cenovus Energy Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Cenovus Energy Inc trades at $29.78 (market cap $55.00B). The key difference: Cenovus Energy Inc is far larger — about 2.4× BioNTech SE - ADR's market cap, and Cenovus Energy Inc pays a 2.09% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | CVE | |
|---|---|---|
Market Cap | $23.31B | $55.00B |
Sector | Health | Energy |
52-Week High | $119.34 | $31.80 |
52-Week Low | $83.89 | $14.83 |
Enterprise Value | $6.60B | $61.08B |
Dividend Yield | — | 2.09% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →